52.000
+4,00%
2026-10-19
Fundamental Analysis
52 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +157.5% | -10.2% | 1 / 3 | -11.7% | +6.01 pp | +1.65 pp | -0.1% | 0.50 | — | 285 | −11,7% | 2,0 | +165,6% | — | 30.77 | — |
| Pts | 12 | 0 | 4 | 0 | 12 | 8 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 52.000 (close price on 2026-10-19)EPS (TTM): −30,9
Financial charts
1.Revenue & growth
VND bn285Q2/26
1.Revenue & growth
VND bn285Q2/26
2.Profit & growth
VND bn1,85Q2/26
3.Profit mix (Penman)
VND bn12,0Q2/26
4.Margins & cost structure
%13.9%Q2/26
5.Returns & cash cycle
% · days-0.2%Q2/26
6.Earnings quality & cash
VND bn143Q2/26
7.Asset structure
VND bn2.390Q2/26
8.Funding & debt health
VND bn · times2.390Q2/26
9.Revenue backlog
VND bn2,31Q2/26
10.Valuation
times · %-1.246,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %25Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-94.0%
averaged over 2 quarter(s)
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26